Health

HaloMD Vows to Defend Providers and the Federal IDR Framework Against Blue Cross Lawsuit
Parent company of Harvard Pilgrim Health Care and Tufts Health Plan, Point32Health, recognized as one of the most community-minded organizations in the country
ENT Partners Expands Midwest Presence with Acquisition of ENT Specialists, Ltd
New Wearable Tech Tracks Astronauts' Sleep Quality on International Space Station
Maryland Stem Cell Research Fund Announces Call for Applications for the July 2025 Cycle
Propedix Inc. Announces Appointment of William Haegele to Board of Directors
Cancer still tops high-cost health claims but muscle and orthopedic conditions are making surprise surge: Sun Life report
CarePredict and ALIS Announce First Ever Automatic Care Tracking for Senior Living
BID Plymouth Hospital RNs Cast Overwhelming Vote to Ratify New Three-Year Contract that Provides Improvements in Staffing, Wages, and Benefits to Increase Recruitment and Retention of Staff Needed to Ensure Safer Patient Care
Medline signs Prime Vendor agreement to supply The Ohio State University Wexner Medical Center
Continuity Biosciences fait l'acquisition de Focal Medical pour faire progresser l'administration ciblée de médicaments contre le cancer du pancréas
MemorialCare Heart & Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair
Research Grid's artificial intelligence automates a 3-year Queen Mary clinical trial in seconds
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
EmpiRx Health Launches New Clinical Review Messaging Solution
Lotus Therapeutics Appoints Leslie Felix as Chief Growth Officer
Metalens Market to Hit USD 2402 Million by 2031, Rising at 79.5% CAGR on Surge in AR/VR and Medical Use | Valuates Reports
The Aspen Group Breaks Down Barriers to Care by Introducing Smile Bridge ℠ in Partnership with the National Foundation for Ectodermal Dysplasias
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen
Kalorama Forecasts $2.3 Billion HbA1c Market by 2029, Driven by POC Growth, Emerging Markets, and Digital Innovation